Article

Evolving Health Policies and Pricing Dynamics in U.S. Multiple Sclerosis Therapies: A Longitudinal Analysis with Policy Implications

2026-04-13

Abstract excerpt

<h4>Background: </h4> and Objectives: Multiple sclerosis (MS) is a chronic autoimmune neuroinflammatory condition associated with significant disability. Given the increasing number of patients with MS, the growing number of available disease-modifying therapies (DMTs), and the substantial economic burden associated with MS, it is critically important to determine which treatment options are the most cost-effectiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4a6cf135-6936-5343-90b6-d5d3f62be20d
DOI: 10.20944/preprints202604.0833.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evolving Health Policies and Pricing Dynamics in U.S. Multiple Sclerosis Therapies: A Longitudinal Analysis with Policy ImplicationsDOI 10.20944/preprints202604.0833.v1Read

The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple SclerosisSemantic proximity Read

Cost-Utility and Cost-Effectiveness Analysis of disease-modifying drugs of Relapsing-Remitting Multiple Sclerosis: A Systematic ReviewSemantic proximity Read

Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.Semantic proximity Read

How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent ExpirySemantic proximity Read

Improving quality of life in multiple sclerosis: an unmet need.Semantic proximity Read

Methodological Challenges in Dutch HTA of Non-Oncological Orphan Drugs: A Retrospective Analysis and Price Comparison Using different Pricing ModelsSemantic proximity Read

Analysis of Health-related quality of life in multiple sclerosis: A Bayesian Quantile LASSO ApproachSemantic proximity Read

Associations of DMT therapies with COVID-19 severity in multiple sclerosisSemantic proximity Read

Applying the Efficiency Frontier to Inform Value-Based Pricing for Gaucher Disease Therapies in BrazilSemantic proximity Read

Guiding the willingness to pay for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome using a cost-based-plus pricing frameworkSemantic proximity Read

Spinal Muscular Atrophy: The High Costs of Innovative Therapies for Rare DiseasesSemantic proximity Read

Prices versus costs of production for molnupiravir as a COVID-19 treatmentSemantic proximity Read